Drug Profile
QR 333
Alternative Names: QR-333Latest Information Update: 02 Feb 2011
Price :
$50
*
At a glance
- Originator Quigley Pharma
- Class Analgesics
- Mechanism of Action Antioxidants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- Discontinued Diabetic neuropathies